Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Bristol-Myers Squibb · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
cardiovascular-risk
plaque psoriasis, deucravacitinib, cardiovascular risk, pragmatyk, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 812786
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.